| 1 |
Abdul Hussein TA, Fadhil HY. Impact of inflammatory markers, dread diseases and cycle threshold (Ct) Values in COVID-19 progression. RB 2023;8:1-8. [DOI: 10.21931/rb/2023.08.01.33] [Reference Citation Analysis]
|
| 2 |
Vujčić I. Outcomes of COVID-19 among patients with liver disease. World J Gastroenterol 2023; 29(5): 815-824 [DOI: 10.3748/wjg.v29.i5.815] [Reference Citation Analysis]
|
| 3 |
Chen Hu, Yu-Kai Liu, Qi-Di Sun, Zheng Du, Yu-Qiang Fang, Fei Guo, Yu-Bo Wang, Yong He, Yuan Cen, Fan Zeng. Clinical characteristics and risk factors for a prolonged length of stay of patients with asymptomatic and mild COVID-19 during the wave of Omicron from Shanghai, China. BMC Infect Dis 2022;22:947. [PMID: 36526990 DOI: 10.1186/s12879-022-07935-w] [Reference Citation Analysis]
|
| 4 |
Afraie M, Mohammadzedeh P, Azami M, Khateri S, Zamani K, Moradpour F, Moradi Y. The association of chronic liver disorders with exacerbation of symptoms and complications related to COVID‐19: A systematic review and meta‐analysis of cohort studies. Clinical Respiratory J 2022. [DOI: 10.1111/crj.13552] [Reference Citation Analysis]
|
| 5 |
Zinellu A, Mangoni AA. A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and COVID-19 progression and mortality. Expert Rev Clin Immunol 2022;:1-16. [PMID: 36047369 DOI: 10.1080/1744666X.2022.2120472] [Reference Citation Analysis]
|
| 6 |
Nagarajan R, Krishnamoorthy Y, Rajaa S, Hariharan VS. COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis. Prev Chronic Dis 2022;19:E53. [PMID: 36007255 DOI: 10.5888/pcd19.210228] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Nicastro E, Ebel NH, Kehar M, Czubkowski P, Ng VL, Michaels MG, Lobritto SJ, Martinez M, Indolfi G. The Impact of Severe Acute Respiratory Syndrome Coronavirus Type 2 on Children With Liver Diseases: A Joint European Society for Pediatric Gastroenterology, Hepatology and Nutrition and Society of Pediatric Liver Transplantation Position Paper. J Pediatr Gastroenterol Nutr 2022;74:159-70. [PMID: 34694269 DOI: 10.1097/MPG.0000000000003339] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 8 |
Sodeifian F, Nikfarjam M, Kian N, Mohamed K, Rezaei N. The role of type I interferon in the treatment of COVID-19. J Med Virol 2021. [PMID: 34468995 DOI: 10.1002/jmv.27317] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 9 |
Philips CA, Kakkar K, Joseph M, Yerol PK, Ahamed R, Rajesh S, Augustine P. Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care. J Clin Transl Hepatol 2021;9:576-86. [PMID: 34447688 DOI: 10.14218/JCTH.2020.00110] [Reference Citation Analysis]
|
| 10 |
Zhou F, Xia J, Yuan HX, Sun Y, Zhang Y. Liver injury in COVID-19: Known and unknown. World J Clin Cases 2021; 9(19): 4980-4989 [PMID: 34307548 DOI: 10.12998/wjcc.v9.i19.4980] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Srivastava S, Garg I. Post COVID-19 infection: Long-term effects on liver and kidneys. World J Meta-Anal 2021; 9(3): 220-233 [DOI: 10.13105/wjma.v9.i3.220] [Reference Citation Analysis]
|
| 12 |
Alwafi H, Naser AY, Qanash S, Brinji AS, Ghazawi MA, Alotaibi B, Alghamdi A, Alrhmani A, Fatehaldin R, Alelyani A, Basfar A, AlBarakati A, Alsharif GF, Obaid EF, Shabrawishi M. Predictors of Length of Hospital Stay, Mortality, and Outcomes Among Hospitalised COVID-19 Patients in Saudi Arabia: A Cross-Sectional Study. J Multidiscip Healthc 2021;14:839-52. [PMID: 33883900 DOI: 10.2147/JMDH.S304788] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
|
